Eton Pharmaceuticals (ETON) Amortizatization of Intangibles (2020 - 2025)
Eton Pharmaceuticals' (ETON) quarterly Amortizatization of Intangibles came in at $175000.0 in Q4 2025, down 83.16% year-over-year from $1.0 million in Q4 2024, and down 7.41% quarter-over-quarter from $189000.0 in Q3 2025.
Powered by 
Analysis
Eton Pharmaceuticals (ETON) Amortizatization of Intangibles (2020 - 2025) Analysis & Trends
Eton Pharmaceuticals has disclosed Amortizatization of Intangibles across 6 years of filings, most recently posting $175000.0 for Q4 2025.
- In Q4 2025, Amortizatization of Intangibles fell 83.16% year-over-year to $175000.0; the TTM figure through Dec 2025 stood at $706000.0 (down 36.74% YoY), while the FY2025 annual figure was $696000.0, down 37.24% from the prior year.
- Amortizatization of Intangibles came in at $175000.0 for Q4 2025 at Eton Pharmaceuticals, down from $189000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.0 million in Q4 2024 to a low of $23000.0 in Q2 2024.
- Average Amortizatization of Intangibles over 5 years is $113700.0, with a median of $36000.0 recorded in 2021.
- Year-over-year, Amortizatization of Intangibles soared 3748.15% in 2024 and plunged 83.16% in 2025.
- Over 5 years, Amortizatization of Intangibles stood at $38000.0 in 2021, then retreated by 18.42% to $31000.0 in 2022, then fell by 12.9% to $27000.0 in 2023, then soared by 3748.15% to $1.0 million in 2024, then plunged by 83.16% to $175000.0 in 2025.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $175000.0 in Q4 2025, $189000.0 in Q3 2025, and $48000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | - |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 984.00 Mn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 4.33 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Eton Pharmaceuticals | 1.63 Bn | 1.60 Bn | 25.41 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 175,000.00 |
| Sep 30, 2025 | 189,000.00 |
| Jun 30, 2025 | 48,000.00 |
| Mar 31, 2025 | 294,000.00 |
| Dec 31, 2024 | 1.04 Mn |
| Sep 30, 2024 | 29,000.00 |
| Jun 30, 2024 | 23,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Dec 31, 2023 | 27,000.00 |
| Sep 30, 2023 | 29,000.00 |
| Jun 30, 2023 | 32,000.00 |
| Mar 31, 2023 | 29,000.00 |
| Dec 31, 2022 | 31,000.00 |
| Sep 30, 2022 | 90,000.00 |
| Jun 30, 2022 | 30,000.00 |
| Mar 31, 2022 | 36,000.00 |
| Dec 31, 2021 | 38,000.00 |
| Sep 30, 2021 | 37,000.00 |
| Jun 30, 2021 | 37,000.00 |
| Mar 31, 2021 | 36,000.00 |